Document is current

Article History

Received: 11 October 2022

Revised: 8 February 2023

Accepted: 7 March 2023

First Online: 23 March 2023

Declarations

:

: This article does not contain any studies with human participants or animals performed by any of the authors.

: Farida Hakim has no affiliations to disclose.Kamran Riaz is a consultant for Immunogen and Ambrx, Inc, has received speaking fees from Bausch and Lomb and CorneaGen, and receives research support from Imprimis Pharmaceuticals, Inc.Asim Farooq is a consultant for Ambrx, Amgen, Eisai, GlaxoSmithKline, Mythic Therapeutics, and Seagen. He also serves on the Clinical Event Review Committee (CERC) for the Zoster Eye Disease Study and is on a Data Monitoring Committee for AstraZeneca.